Role of endocannabinoids in alcohol consumption and intoxication: Studies of mice lacking fatty acid amide hydrolase

被引:96
作者
Blednov, Yuri A.
Cravatt, Benjamin F.
Boehm, Stephen L., II
Walker, Danielle
Harris, R. Adron
机构
[1] Univ Texas, Dept Neurobiol, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA
[2] Scripps Res Inst, Dept Cell Biol & Chem, La Jolla, CA USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA USA
[4] SUNY Binghamton, Dept Psychol, Behav Neurosci Program, Binghamton, NY USA
关键词
FAAH; anandamide; mutant mouse; ethanol intake; tolerance; LORR;
D O I
10.1038/sj.npp.1301274
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Endocannabinoid signaling plays the important role in regulation of ethanol intake. Fatty acid amide hydrolase ( FAAH) is a key membrane protein for metabolism of endocannabinoids, including anandamide, and blockade of FAAH increases the level of anandamide in the brain. To determine if FAAH regulates ethanol consumption, we studied mutant mice with deletion of the FAAH gene. Null mutant mice showed higher preference for alcohol and voluntarily consumed more alcohol than wild-type littermates. There was no significant difference in consumption of sweet or bitter solutions. To determine the specificity of FAAH for ethanol intake, we studied additional ethanol-related behaviors. There were no differences between null mutant and wild-type mice in severity of ethanol-induced acute withdrawal, conditioned taste aversion to alcohol, conditioned place preference, or sensitivity to hypnotic effect of ethanol. However, null mutant mice showed shorter duration of loss of righting reflex induced by low doses of ethanol (3.2 and 3.4 g/kg) and faster recovery from motor incoordination induced by ethanol. All three behavioral phenotypes ( increased preference for ethanol, decreased sensitivity to ethanol-induced sedation, and faster recovery from ethanol-induced motor incoordination) seen in mutant mice were reproduced in wild-type mice by injection of a specific inhibitor of FAAH activity-URB597. These data suggest that increased endocannabinoid signaling increased ethanol consumption owing to decreased acute ethanol intoxication.
引用
收藏
页码:1570 / 1582
页数:13
相关论文
共 60 条
[1]
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors [J].
Arnone, M ;
Maruani, J ;
Chaperon, F ;
Thiebot, MH ;
Poncelet, M ;
Soubrie, P ;
LeFur, G .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :104-106
[2]
Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice [J].
Basavarajappa, Balapal S. ;
Yalamanchili, Ratnakumar ;
Cravatt, Benjamin F. ;
Cooper, Thomas B. ;
Hungund, Basalingappa L. .
NEUROPHARMACOLOGY, 2006, 50 (07) :834-844
[3]
Role of the endocannabinoid system in the development of tolerance to alcohol [J].
Basavarajappa, BS ;
Hungund, BL .
ALCOHOL AND ALCOHOLISM, 2005, 40 (01) :15-24
[4]
Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells [J].
Basavarajappa, BS ;
Hungund, BL .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :522-528
[5]
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons [J].
Basavarajappa, BS ;
Saito, M ;
Cooper, TB ;
Hungund, BL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1535 (01) :78-86
[6]
Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse [J].
Basavarajappa, BS ;
Hungund, BL .
BRAIN RESEARCH, 1999, 815 (01) :89-97
[7]
Bennett B, 1998, MAMM GENOME, V9, P969
[8]
GABAA receptor α1 and β2 subunit null mutant mice:: Behavioral responses to ethanol [J].
Blednov, YA ;
Walker, D ;
Alva, H ;
Creech, K ;
Findlay, G ;
Harris, RA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :854-863
[9]
Deletion of the α1 or β2 subunit of GABAA receptors reduces actions of alcohol and other drugs [J].
Blednov, YA ;
Jung, S ;
Alva, H ;
Wallace, D ;
Rosahl, T ;
Whiting, PJ ;
Harris, RA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01) :30-36
[10]
Blednov YA, 2001, J PHARMACOL EXP THER, V298, P521